U.S. Pharmacist Vaccine Update

July 2020

One-Fourth of U.S. Adults Would Refuse COVID-19 Vaccine
Pharmacists are likely to be faced with the same sales job with the COVID-19 vaccine as they are with immunization against other infections. While most U.S. adults say that they consider vaccines to be safe and effective, nearly one-fourth state that they don’t feel comfortable being vaccinated against the novel coronavirus; the percentage rose to nearly one-third among Republicans and independents. Here are more details.

Researchers: MMR Vaccine Could Protect Against COVID-19
COVID-19 appears to be less serious in patients who have received live attenuated vaccine—measles, mumps, rubella (MMR), in this case—and that might be a solution to reducing the septic inflammation associated with COVID-19, according to a recent article. Find out why the authors suggest MMR vaccination in some adults, including healthcare workers, even before a clinical trial is conducted.

Avoiding Herpes Zoster Far Outweighs Minor RZV Effects
The two-dose recombinant zoster vaccine (RZV) has minimal effect on patient function or quality of life (QoL), according to a recent study. That’s why researchers conclude that those minor issues are far outweighed by the QoL decline from herpes zoster and related acute episode-associated pain and postherpetic neuralgia. Here is more information.

Connect With U.S. Pharmacist